GMAB logo

Genmab A/S (GMAB) Cash From Operations

Annual CFO

$1.07 B
+$516.91 M+93.21%

December 31, 2023


Summary


Performance

GMAB Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

Quarterly CFO

$308.77 M
+$92.36 M+42.68%

September 1, 2024


Summary


Performance

GMAB Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

TTM CFO

$983.47 M
+$11.74 M+1.21%

September 1, 2024


Summary


Performance

GMAB TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGMABcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

GMAB Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+93.2%+4.0%+7.8%
3 y3 years+8.7%-33.8%+5.5%
5 y5 years+566.4%-33.8%+5.5%

GMAB Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+202.2%-33.8%+681.7%-8.2%+291.9%
5 y5-yearat high+438.9%-62.3%+305.5%-15.5%+497.0%
alltimeall timeat high+1104.3%-62.3%+305.5%-15.5%+935.6%

Genmab A/S Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$308.77 M(+42.7%)
$983.47 M(+1.2%)
Jun 2024
-
$216.41 M(-1.8%)
$971.73 M(+17.7%)
Mar 2024
-
$220.38 M(-7.4%)
$825.32 M(-23.0%)
Dec 2023
$1.07 B(+93.2%)
$237.91 M(-19.9%)
$1.07 B(+17.4%)
Sep 2023
-
$297.03 M(+324.3%)
$912.39 M(+4.9%)
Jun 2023
-
$70.00 M(-85.0%)
$869.77 M(-6.7%)
Mar 2023
-
$466.53 M(+491.8%)
$932.55 M(+68.2%)
Dec 2022
$554.57 M(+56.4%)
$78.83 M(-69.0%)
$554.57 M(+7.6%)
Sep 2022
-
$254.41 M(+91.6%)
$515.24 M(+57.9%)
Jun 2022
-
$132.78 M(+49.9%)
$326.27 M(+30.0%)
Mar 2022
-
$88.55 M(+124.2%)
$250.97 M(-29.2%)
Dec 2021
$354.52 M(-64.0%)
$39.50 M(-39.6%)
$354.52 M(+115.2%)
Sep 2021
-
$65.44 M(+13.9%)
$164.75 M(-82.0%)
Jun 2021
-
$57.48 M(-70.1%)
$917.29 M(+2.5%)
Mar 2021
-
$192.10 M(-227.8%)
$895.20 M(-9.2%)
Dec 2020
$985.67 M(+395.7%)
-$150.27 M(-118.4%)
$985.67 M(-15.3%)
Sep 2020
-
$817.99 M(+2211.4%)
$1.16 B(+197.1%)
Jun 2020
-
$35.39 M(-87.5%)
$391.61 M(+2.3%)
Mar 2020
-
$282.57 M(+932.7%)
$382.77 M(+92.5%)
Dec 2019
$198.82 M(+23.7%)
$27.36 M(-40.9%)
$198.82 M(-3.4%)
Sep 2019
-
$46.29 M(+74.3%)
$205.83 M(+8.3%)
Jun 2019
-
$26.55 M(-73.1%)
$189.98 M(+3.9%)
Mar 2019
-
$98.62 M(+187.0%)
$182.84 M(+13.7%)
Dec 2018
$160.78 M(-33.5%)
$34.36 M(+12.9%)
$160.78 M(+2.5%)
Sep 2018
-
$30.45 M(+56.9%)
$156.85 M(+7.3%)
Jun 2018
-
$19.41 M(-74.6%)
$146.22 M(-30.6%)
Mar 2018
-
$76.56 M(+151.6%)
$210.71 M(-12.9%)
Dec 2017
$241.87 M(+396.5%)
$30.43 M(+53.6%)
$241.87 M(+21.4%)
Sep 2017
-
$19.82 M(-76.4%)
$199.27 M(-5.0%)
Jun 2017
-
$83.90 M(-22.1%)
$209.77 M(+33.0%)
Mar 2017
-
$107.72 M(-985.4%)
$157.71 M(+223.8%)
Dec 2016
$48.71 M(+5.1%)
-$12.17 M(-140.1%)
$48.71 M(-50.5%)
Sep 2016
-
$30.32 M(-4.8%)
$98.31 M(+11.1%)
Jun 2016
-
$31.84 M(-2593.4%)
$88.51 M(+65.6%)
Mar 2016
-
-$1.28 M(-103.4%)
$53.45 M(+15.4%)
DateAnnualQuarterlyTTM
Dec 2015
$46.34 M(+95.8%)
$37.44 M(+82.5%)
$46.34 M(+330.9%)
Sep 2015
-
$20.51 M(-736.4%)
$10.75 M(+72.4%)
Jun 2015
-
-$3.22 M(-61.6%)
$6.24 M(-67.2%)
Mar 2015
-
-$8.39 M(-552.9%)
$19.01 M(-19.7%)
Dec 2014
$23.66 M(-203.8%)
$1.85 M(-88.4%)
$23.66 M(+21.4%)
Sep 2014
-
$16.00 M(+67.6%)
$19.49 M(-455.5%)
Jun 2014
-
$9.54 M(-355.7%)
-$5.48 M(-71.7%)
Mar 2014
-
-$3.73 M(+60.7%)
-$19.35 M(-15.1%)
Dec 2013
-$22.79 M(-286.1%)
-$2.32 M(-74.1%)
-$22.79 M(-12.0%)
Sep 2013
-
-$8.97 M(+107.6%)
-$25.90 M(-199.6%)
Jun 2013
-
-$4.32 M(-39.8%)
$26.00 M(+51.6%)
Mar 2013
-
-$7.18 M(+32.1%)
$17.16 M(+40.1%)
Dec 2012
$12.25 M(-115.0%)
-$5.43 M(-112.7%)
$12.25 M(-497.5%)
Sep 2012
-
$42.93 M(-426.1%)
-$3.08 M(-95.3%)
Jun 2012
-
-$13.17 M(+8.9%)
-$65.35 M(-18.8%)
Mar 2012
-
-$12.09 M(-41.8%)
-$80.45 M(-1.5%)
Dec 2011
-$81.68 M(-271.1%)
-$20.76 M(+7.3%)
-$81.68 M(-3.0%)
Sep 2011
-
-$19.34 M(-31.6%)
-$84.23 M(-223.3%)
Jun 2011
-
-$28.27 M(+112.4%)
$68.34 M(-8.9%)
Mar 2011
-
-$13.31 M(-42.9%)
$75.01 M(+57.1%)
Dec 2010
$47.74 M(-144.7%)
-$23.32 M(-117.5%)
$47.74 M(-15.0%)
Sep 2010
-
$133.23 M(-717.0%)
$56.15 M(-147.7%)
Jun 2010
-
-$21.59 M(-46.8%)
-$117.69 M(+3.1%)
Mar 2010
-
-$40.58 M(+172.2%)
-$114.17 M(+7.0%)
Dec 2009
-$106.69 M(+5.5%)
-$14.91 M(-63.3%)
-$106.69 M(+16.2%)
Sep 2009
-
-$40.61 M(+124.7%)
-$91.78 M(+79.4%)
Jun 2009
-
-$18.08 M(-45.4%)
-$51.17 M(+54.6%)
Mar 2009
-
-$33.09 M
-$33.09 M
Dec 2008
-$101.12 M(-208.7%)
-
-
Dec 2007
$93.03 M(-245.5%)
-
-
Dec 2006
-$63.94 M(+83.5%)
-
-
Dec 2005
-$34.85 M(-43.3%)
-
-
Dec 2004
-$61.50 M(+33.6%)
-
-
Dec 2003
-$46.03 M(+17.3%)
-
-
Dec 2002
-$39.23 M
-
-

FAQ

  • What is Genmab A/S annual cash flow from operations?
  • What is the all time high annual CFO for Genmab A/S?
  • What is Genmab A/S annual CFO year-on-year change?
  • What is Genmab A/S quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Genmab A/S?
  • What is Genmab A/S quarterly CFO year-on-year change?
  • What is Genmab A/S TTM cash flow from operations?
  • What is the all time high TTM CFO for Genmab A/S?
  • What is Genmab A/S TTM CFO year-on-year change?

What is Genmab A/S annual cash flow from operations?

The current annual CFO of GMAB is $1.07 B

What is the all time high annual CFO for Genmab A/S?

Genmab A/S all-time high annual cash flow from operations is $1.07 B

What is Genmab A/S annual CFO year-on-year change?

Over the past year, GMAB annual cash flow from operations has changed by +$516.91 M (+93.21%)

What is Genmab A/S quarterly cash flow from operations?

The current quarterly CFO of GMAB is $308.77 M

What is the all time high quarterly CFO for Genmab A/S?

Genmab A/S all-time high quarterly cash flow from operations is $817.99 M

What is Genmab A/S quarterly CFO year-on-year change?

Over the past year, GMAB quarterly cash flow from operations has changed by +$11.74 M (+3.95%)

What is Genmab A/S TTM cash flow from operations?

The current TTM CFO of GMAB is $983.47 M

What is the all time high TTM CFO for Genmab A/S?

Genmab A/S all-time high TTM cash flow from operations is $1.16 B

What is Genmab A/S TTM CFO year-on-year change?

Over the past year, GMAB TTM cash flow from operations has changed by +$71.07 M (+7.79%)